Cas:13818-89-8 λ3-germane manufacturer & supplier

We serve Chemical Name:λ3-germane CAS:13818-89-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

λ3-germane

Chemical Name:λ3-germane
CAS.NO:13818-89-8
Synonyms:Germaniumhydride (Ge2H6) (6CI);Digermane (7CI,8CI,9CI);Digermane (Ge2H6)
Molecular Formula:Ge2H6
Molecular Weight:151.32800
HS Code:

Physical and Chemical Properties:
Melting point:-109ºC
Boiling point:31ºC
Density:N/A
Index of Refraction:
PSA:
Exact Mass:153.88900
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1409
Packing Group:


Contact us for information like Germaniumhydride (Ge2H6) (6CI) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Digermane (Ge2H6) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Digermane (7CI,8CI,9CI) Use and application,Digermane (Ge2H6) technical grade,usp/ep/jp grade.


Related News: In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. λ3-germane manufacturer In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. λ3-germane supplier Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry. λ3-germane vendor By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. λ3-germane factory In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company.